A Study of the Safety and Efficacy of the Combination of Gemcitabine and Docetaxel in Metastatic Soft Tissue Sarcoma

Trial Profile

A Study of the Safety and Efficacy of the Combination of Gemcitabine and Docetaxel in Metastatic Soft Tissue Sarcoma

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Dec 2016

At a glance

  • Drugs Ontuxizumab (Primary) ; Docetaxel; Gemcitabine
  • Indications Soft tissue sarcoma
  • Focus Therapeutic Use
  • Acronyms SOURCE
  • Sponsors Morphotek
  • Most Recent Events

    • 28 Sep 2016 Status changed from active, no longer recruiting to completed.
    • 28 Apr 2016 Planned End Date changed from 1 Apr 2016 to 1 May 2016.
    • 15 Apr 2016 Planned End Date changed from 1 Mar 2016 to 1 Apr 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top